FC
LLY icon

Farringdon Capital’s Eli Lilly LLY Stock Holding History

Farringdon Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.73M Sell
1,877
-780
-29% -$791K 0.38% 85
2025
Q4 		$2.86M Buy
2,657
+1,721
+184% +$1.65M 0.7% 29
2025
Q3 		$714K Buy
936
+440
+89% +$327K 0.18% 171
2025
Q2 		$387K Buy
+496
New +$385K 0.13% 266
2025
Q1 		– Sell
-1,236
Closed -$954K – 489
2024
Q4 		$954K Buy
+1,236
New +$1.02M 0.39% 48

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Farringdon Capital's LLY Position: Q1 2026 in Review

Farringdon Capital reduced its Eli Lilly (LLY) stake by 29% in Q1 2026, selling an estimated $791K and leaving 1,877 shares worth $1.73M. The position accounts for 0.38% of the portfolio, ranked #85.

Farringdon Capital first reported a position in LLY in Q4 2024 and has held it in 5 quarters since. The position peaked at $2.86M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Farringdon Capital held 1,877 shares of Eli Lilly worth $1.73M as of Q1 2026.
  • Farringdon Capital sold 780 Eli Lilly shares in Q1 2026, an estimated $791K.
  • Eli Lilly made up 0.38% of Farringdon Capital's portfolio in Q1 2026, its #85 holding.
  • Farringdon Capital first reported a position in Eli Lilly in Q4 2024 and has held it in 5 quarters since.
  • Farringdon Capital's Eli Lilly position peaked at $2.86M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Farringdon Capital's 13F filing for Q1 2026, filed 15 May 2026.